Bottom line
Is JCNRX a good fund? The bottom line
JCNRX is the Class R share class of Janus Henderson Contrarian Fund, an actively managed large blend mutual fund from Janus Henderson.
Annual fees run 1.37% — about $137 a year on every $10,000 invested, more expensive than 80% of large blend funds we track.
With $5.5 billion in net assets and 45 holdings, its largest position is Nebius Group NV (5.8%) and the top 10 make up 46.4% of the portfolio.
What stands out
- No front-end sales load
What to watch
- Expensive for its category (1.37%)
- 12b-1 marketing fee of 0.5% a year
Updated Nov 19, 2026
What JCNRX invests in
Janus Henderson Contrarian Fund seeks long-term growth of capital.
The Fund pursues its investment objective by primarily investing in equity securities. The Fund normally invests in a portfolio of 35-55 common stocks. Portfolio management seeks to invest in companies where the stock price trades at a significant discount to portfolio managements estimate of intrinsic value and whose intrinsic value portfolio management believes will grow over time. The Fund is classified as nondiversified, which allows it to hold larger positions in more securities as compared to a fund that is classified as diversified. The Fund may invest in companies of any size, from larger, well-established companies to smaller, emerging growth companies. The Fund may invest in foreign securities. Portfolio management applies a bottom-up approach in choosing investments. In other words, portfolio management looks at companies one at a time to determine if a company is an…
From the fund's prospectus (filed Jan 28, 2026).
What JCNRX costs
On a $10,000 investment, JCNRX's 1.37% expense ratio costs about $137 a year. The prospectus estimates $1,687 in total costs over 10 years (assuming 5% annual returns). The median large blend fund charges 0.83%.
JCNRX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Nebius Group NV | 5.76% |
| 2 | Marvell Technology, Inc. | 5.53% |
| 3 | Taiwan Semiconductor Manufacturing Co. Ltd. | 5.40% |
| 4 | Janus Henderson Cash Liquidity Fund LLC | 5.07% |
| 5 | PNC Financial Services Group, Inc. (The) | 4.35% |
| 6 | Capital One Financial Corp. | 4.35% |
| 7 | Surgery Partners, Inc. | 4.06% |
| 8 | UnitedHealth Group, Inc. | 4.05% |
| 9 | Lumentum Holdings, Inc. | 3.98% |
| 10 | Oracle Corp. | 3.83% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 46.4% of the fund. See all top 25 holdings and asset mix →